Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of ciprofol combined with alfentanil for movement suppression during cervical dilatation in hysteroscopic surgery
ChiCTR2400081765Phase 4Not yet recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Mar 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol, sponsored by Hangzhou Red Cross Hospital. Primary endpoints: Body movement during cervical dilatation, Adverse events during anesthesia induction and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2400081765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081765.